NCT07435012Phase 3Recruiting
Androgenic Alopecia TH07 Clinical Trial
Phase III, Parallel Design, Triple-Blind, Randomized, Multicenter Clinical Trial to Evaluate Safety & Efficacy of TH07 Topical Treatment in Male Patients With Androgenic Alopecia.
In the register
The register attaches this trial to TH07 (Triple Hair), currently at “Phase 3” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Recruiting
- Declared phase
- Phase 3
- Sponsor
- Triple Hair Inc
- Participants (registry)
- 420
- Start
- April 2026
- Primary completion
- December 2027 (planned)
- Study completion
- April 2028 (planned)
- Last registry update
- March 2026
- Countries
- Canada
Conditions studied: Androgenic Alopecia
Interventions: TH07, TH07, Minoxidil 5% Topical Solution, Placebo
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.